$46.9 Million is the total value of Connective Portfolio Management, LLC's 49 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 933.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GILD | Buy | GILEAD SCIENCES INC | $2,727,500 | +275.7% | 31,770 | +169.9% | 5.82% | +151.3% |
MCHI | New | ISHARES TRmsci china etf | $1,900,000 | – | 40,000 | +100.0% | 4.05% | – |
BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $1,880,400 | – | 170,000 | +100.0% | 4.01% | – |
REGN | Buy | REGENERON PHARMACEUTICALS | $1,857,800 | +24.4% | 2,575 | +24.1% | 3.96% | -16.8% |
SMFG | New | SUMITOMO MITSUI FINL GROUP Isponsored adr | $1,764,400 | – | 220,000 | +100.0% | 3.76% | – |
XLU | New | SELECT SECTOR SPDR TRsbi int-utils | $1,762,500 | – | 25,000 | +100.0% | 3.76% | – |
VDC | New | VANGUARD WORLD FDSconsum stp etf | $1,724,100 | – | 9,000 | +100.0% | 3.68% | – |
IBN | New | ICICI BANK LIMITEDadr | $1,576,100 | – | 72,000 | +100.0% | 3.36% | – |
HDB | New | HDFC BANK LTDsponsored ads | $1,436,600 | – | 21,000 | +100.0% | 3.06% | – |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $1,345,400 | – | 13,000 | +100.0% | 2.87% | – |
KXI | New | ISHARES TRglb cnsm stp etf | $1,312,100 | – | 22,000 | +100.0% | 2.80% | – |
STNG | New | SCORPIO TANKERS INC | $1,290,500 | – | 24,000 | +100.0% | 2.75% | – |
PWR | Buy | QUANTA SVCS INC | $1,140,000 | +24.0% | 8,000 | +14.3% | 2.43% | -17.0% |
FTI | New | TECHNIPFMC PLC | $1,133,700 | – | 93,000 | +100.0% | 2.42% | – |
ITA | New | ISHARES TRus aer def etf | $1,129,800 | – | 10,100 | +100.0% | 2.41% | – |
WFRD | New | WEATHERFORD INTL PLC | $1,120,200 | – | 22,000 | +100.0% | 2.39% | – |
TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $1,017,600 | – | 13,660 | +100.0% | 2.17% | – |
RXDX | New | PROMETHEUS BIOSCIENCES INC | $990,000 | – | 9,000 | +100.0% | 2.11% | – |
CRWD | New | CROWDSTRIKE HLDGS INCcl a | $895,000 | – | 8,500 | +100.0% | 1.91% | – |
COUP | New | COUPA SOFTWARE INC | $791,700 | – | 10,000 | +100.0% | 1.69% | – |
ARGX | New | ARGENX SEsponsored adr | $725,500 | – | 1,915 | +100.0% | 1.55% | – |
BP | New | BP PLCsponsored adr | $719,600 | – | 20,600 | +100.0% | 1.54% | – |
PANW | New | PALO ALTO NETWORKS INC | $697,700 | – | 5,000 | +100.0% | 1.49% | – |
New | VENTYX BIOSCIENCES INC | $491,900 | – | 15,000 | +100.0% | 1.05% | – | |
BNTX | New | BIONTECH SEsponsored ads | $466,500 | – | 2,800 | +100.0% | 1.00% | – |
BGNE | New | BEIGENE LTDsponsored adr | $439,900 | – | 2,000 | +100.0% | 0.94% | – |
ENPH | New | ENPHASE ENERGY INC | $397,400 | – | 1,500 | +100.0% | 0.85% | – |
SRPT | New | SAREPTA THERAPEUTICS INC | $388,700 | – | 3,000 | +100.0% | 0.83% | – |
TENB | New | TENABLE HLDGS INC | $381,500 | – | 10,000 | +100.0% | 0.81% | – |
FIVN | New | FIVE9 INC | $339,300 | – | 5,000 | +100.0% | 0.72% | – |
KLAC | New | KLA CORP | $301,600 | – | 800 | +100.0% | 0.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-01-25
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 8 | Q3 2023 | 8.4% |
NVIDIA CORPORATION | 8 | Q3 2023 | 8.2% |
ISHARES GOLD TR | 8 | Q3 2023 | 3.9% |
CHIPOTLE MEXICAN GRILL INC | 8 | Q3 2023 | 3.6% |
SPDR GOLD TR | 8 | Q3 2023 | 3.4% |
REGENERON PHARMACEUTICALS | 8 | Q3 2023 | 4.8% |
PROCTER AND GAMBLE CO | 8 | Q3 2023 | 2.0% |
MASTERCARD INCORPORATED | 8 | Q3 2023 | 1.4% |
TESLA INC | 7 | Q3 2023 | 7.0% |
HESS CORP | 7 | Q3 2023 | 4.7% |
View Connective Portfolio Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-17 |
13F-HR | 2023-10-19 |
13F-HR | 2023-07-17 |
13F-HR | 2023-04-17 |
13F-HR | 2023-01-25 |
13F-HR | 2022-10-26 |
13F-HR | 2022-07-18 |
13F-HR | 2022-04-12 |
13F-HR | 2022-02-07 |
View Connective Portfolio Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.